Brightgene Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BRIGHTGENE, and what generic and branded alternatives to BRIGHTGENE drugs are available?
BRIGHTGENE has one approved drug.
Drugs and US Patents for Brightgene
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Brightgene | ENTECAVIR | entecavir | TABLET;ORAL | 212126-001 | Sep 25, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Brightgene | ENTECAVIR | entecavir | TABLET;ORAL | 212126-002 | Sep 25, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.